1. Home
  2. RDHL vs MARPS Comparison

RDHL vs MARPS Comparison

Compare RDHL & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MARPS
  • Stock Information
  • Founded
  • RDHL 2009
  • MARPS 1956
  • Country
  • RDHL Israel
  • MARPS United States
  • Employees
  • RDHL N/A
  • MARPS N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MARPS Oil & Gas Production
  • Sector
  • RDHL Health Care
  • MARPS Energy
  • Exchange
  • RDHL Nasdaq
  • MARPS Nasdaq
  • Market Cap
  • RDHL 8.2M
  • MARPS 8.7M
  • IPO Year
  • RDHL N/A
  • MARPS N/A
  • Fundamental
  • Price
  • RDHL $5.58
  • MARPS $4.05
  • Analyst Decision
  • RDHL
  • MARPS
  • Analyst Count
  • RDHL 0
  • MARPS 0
  • Target Price
  • RDHL N/A
  • MARPS N/A
  • AVG Volume (30 Days)
  • RDHL 10.4K
  • MARPS 21.6K
  • Earning Date
  • RDHL 04-07-2025
  • MARPS 01-01-0001
  • Dividend Yield
  • RDHL N/A
  • MARPS 8.88%
  • EPS Growth
  • RDHL N/A
  • MARPS N/A
  • EPS
  • RDHL N/A
  • MARPS 0.36
  • Revenue
  • RDHL $3,707,000.00
  • MARPS $1,042,513.00
  • Revenue This Year
  • RDHL $224.90
  • MARPS N/A
  • Revenue Next Year
  • RDHL $82.69
  • MARPS N/A
  • P/E Ratio
  • RDHL N/A
  • MARPS $11.13
  • Revenue Growth
  • RDHL N/A
  • MARPS N/A
  • 52 Week Low
  • RDHL $5.41
  • MARPS $3.76
  • 52 Week High
  • RDHL $20.28
  • MARPS $6.50
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 35.64
  • MARPS 49.16
  • Support Level
  • RDHL $5.50
  • MARPS $3.81
  • Resistance Level
  • RDHL $6.26
  • MARPS $4.20
  • Average True Range (ATR)
  • RDHL 0.32
  • MARPS 0.18
  • MACD
  • RDHL -0.02
  • MARPS -0.02
  • Stochastic Oscillator
  • RDHL 3.08
  • MARPS 27.01

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

Share on Social Networks: